Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2025 08:24 ET | Source: Research and Markets

EpCAM-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of EpCAM-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
November 17, 2025 10:00 ET | Source: Dewpoint Therapeutics

FDA Grants Fast Track Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer

U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Dewpoint Therapeutics' DPTX3186
October 29, 2025 10:00 ET | Source: Dewpoint Therapeutics

FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer

Dewpoint's DPTX3186 receives FDA Orphan Drug Designation for gastric cancer - the first ever granted to a condensate-modulating therapeutic.
August 14, 2025 08:19 ET | Source: Biomerica, Inc.

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use

10-minute home test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerH. pylori linked to approximately 80% of gastric cancer cases; classified...
August 11, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Gastric Cancer Market on Growth Trajectory: Novel Therapies Drive Momentum Through 2034 | DelveInsight

New York, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Gastric Cancer Market on Growth Trajectory: Novel Therapies Drive Momentum Through 2034 | DelveInsight The outlook for the gastric cancer treatment...
April 23, 2025 08:19 ET | Source: Biomerica, Inc.

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection

10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproximately 80% of gastric cancer cases are linked to H. pylori infection; WHO...
August 20, 2024 10:38 ET | Source: Transparency Market Research

Companion Diagnostics Market Size to Hit USD 9.3 Billion Revenue by 2028 with 9% CAGR: Report by Transparency Market Research

Wilmington, Delaware, United States, Transparency Market Research Inc., Aug. 20, 2024 (GLOBE NEWSWIRE) -- The global companion diagnostics market (동반진단 시장) was worth US$ 5.2 Bn in 2020 and is...
March 20, 2024 11:13 ET | Source: Research and Markets

Global Cancer Cachexia Market Worth $2.85 Billion by 2029: Combination Therapies Gaining Traction

Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. This research report sheds light...
January 23, 2024 08:19 ET | Source: Biomerica, Inc.

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully built...
December 18, 2023 07:47 ET | Source: Biomerica, Inc.

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Over 80% of gastric cancers are attributed to H. pylori bacterial infection Gastric cancer is the third most common cause of cancer related death in the world ...